Cargando…

Using NT-proBNP to Detect Chronic Heart Failure in Elderly Patients with Chronic Obstructive Pulmonary Disease

Objective. To detect chronic heart failure in elderly patients with a registered diagnosis of chronic obstructive pulmonary disease (COPD) treated in Swedish primary health care using natriuretic peptide NT-proBNP. Design. A cross-sectional study. Setting. Two primary health care centres in southeas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaszuba, Elzbieta, Wagner, Bartlomiej, Odeberg, Håkan, Halling, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041248/ https://www.ncbi.nlm.nih.gov/pubmed/24967321 http://dx.doi.org/10.5402/2013/273864

Ejemplares similares

NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure
por: Pan, Yesheng, et al.
Publicado: (2017)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based study
por: Kaszuba, Elzbieta, et al.
Publicado: (2016)

Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study
por: Kaszuba, Elzbieta, et al.
Publicado: (2018)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis
por: Wang, Qing-ping, et al.
Publicado: (2013)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

The relationship between NT-proBNP and Depression in Patients with Heart Failure
por: Gao, Ying–Hui, et al.
Publicado: (2017)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

NT-proBNP predicts the need for ventilatory support in the patients with acute exacerbation of chronic obstructive pulmonary disease
por: Kuharic, J, et al.
Publicado: (2015)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Correction: Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis
por: Wang, Qing-ping, et al.
Publicado: (2013)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

NT-ProBNP Levels in Saliva and Its Clinical Relevance to Heart Failure
por: Foo, Jared Yong Yang, et al.
Publicado: (2012)

NT-proBNP: A Guide to Improve the Management of Patients with Heart Failure
por: Latini, Roberto, et al.
Publicado: (2014)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
por: Komarnicki, Paweł, et al.
Publicado: (2023)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

Use of NT-proBNP in weaning from mechanical ventilation
por: Martini, A, et al.
Publicado: (2011)

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008)

Rise and fall of NT-proBNP in aortic valve intervention
por: Hultkvist, Henrik, et al.
Publicado: (2018)

Highly sensitive detection of NT-proBNP by molecular motor
por: Zhang, Jie, et al.
Publicado: (2016)

In-hospital mortality is associated with high NT-proBNP level
por: Benmachiche, Malik, et al.
Publicado: (2018)

Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?
por: da Silva, Luís Beck
Publicado: (2019)

NT‐proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure
por: Parovic, Milos, et al.
Publicado: (2019)

Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
por: Li, Zhiyong, et al.
Publicado: (2022)

NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease
por: Skrzypczyk, Piotr, et al.
Publicado: (2021)

Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination
por: Sabatasso, Sara, et al.
Publicado: (2011)

Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
por: Cabré, Anna, et al.
Publicado: (2013)

Inflammatory markers and incident heart failure in older men: the role of NT-proBNP
por: McKechnie, Douglas GJ, et al.
Publicado: (2021)

NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
por: Schmitt, Walter, et al.
Publicado: (2021)

Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
por: Wolodimeroff, Elena, et al.
Publicado: (2022)

Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failure
por: Liang, Lin, et al.
Publicado: (2022)

Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
por: Aoki, Shoko, et al.
Publicado: (2022)

NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure
por: Sarzani, Riccardo, et al.
Publicado: (2016)

NT‐ProBNP and high‐sensitivity troponin T as screening tests for subclinical chronic heart failure in a general population
por: Averina, Maria, et al.
Publicado: (2022)

The Ratio of NT-proBNP to CysC(1.53) Predicts Heart Failure in Patients With Chronic Kidney Disease
por: Wang, Sheng, et al.
Publicado: (2021)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_uj5eevk7e5rrrhom41n8dn1d9a